Recent Finacing
Recent Raise
Terapio develops RLIP76-based therapeutics, focusing on a preclinical oral radiation countermeasure shown to improve survival in animal models and drug-delivery applications, preparing for IND-enabling studies.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor